High ‐sensitivity C‐reactive Protein, Low‐Density Lipoprotein Cholesterol, and Cardiovascular Outcomes in Patients with Type 2 Diabetes in the EXAMINE (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care) Trial

ConclusionsLevels of hsCRP were associated with recurrent cardiovascular events in patients with type 2 diabetes and recent acute coronary syndrome, and this association appears to be independent of and additive to the achieved LDL‐C level.Clinical trials registration number: NCT00968708

Source: Diabetes, Obesity and Metabolism - October 24, 2017 Category: Endocrinology Authors: You ‐Cheol Hwang, David A. Morrow, Christopher P. Cannon, Yuyin Liu, Richard Bergenstal, Simon Heller, Cyrus Mehta, William Cushman, George L Bakris, Faiez Zannad, William B White Tags: ORIGINAL ARTICLE Source Type: research